|Document ID (ISN)||102923|
|ISSN - Serial title
||1076-2752 - Journal of Occupational and Environmental Medicine
|Convention or series no.
||Burton W.N., Morrison A., Wertheimer A.I.
||Pharmaceuticals and worker productivity loss: A critical review of the literature
||June 2003, Vol.45, No.6, p.610-621. Illus. 87 ref.
||Many chronic illnesses that affect the working population can cause losses in productivity. The extent to which these productivity losses can be reduced by pharmacological treatment is of particular interest to employers, who bear the costs of productivity losses and of employees' health care. This article consists of a summary and critical review of various earlier studies on the effects of pharmaceuticals on productivity losses. For a dozen drug classes, there is good evidence that pharmaceuticals reduce productivity losses caused by respiratory illnesses (such as asthma, allergic disorders, bronchitis, upper respiratory infections, and influenza), diabetes, depression, dysmenorrhoea and migraine. In many cases, the reduction in productivity loss may partially or completely offset the costs of treatment. These results should be helpful to occupational physicians in providing recommendations on employer benefit plan designs taking into account the benefits of pharmacological treatments.
||pharmaceutical products; plant health organization; medical treatment; work efficiency; pharmacological prevention
||literature survey; influenza; migraine; depressive neurosis; bronchitis; allergic respiratory disorders; upper respiratory diseases; menstrual disorders; economic aspects; industrial physicians; asthma
||D - Periodical articles
|Country / State or Province||USA|
|Broad subject area(s)
||Occupational medicine, epidemiology
Occupational health services
Bacterial and parasitic diseases
Viral diseases (other than aids)